Medications

FDA panel endorses first lower-cost biotech drug

Federal health experts have unanimously endorsed a Novartis drug which is expected to become the first lower-cost copy of a biotech drug to reach the U.S. market.

Medications

FDA drug approvals reached 18-year high in 2014

The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.

Health

Poll: Americans support menu labeling

Most Americans favor labeling calories on menus in fast food and sit-down restaurants. That's according to an Associated Press-GfK poll conducted in December that found most favor labels for prepared foods in the grocery ...

Diseases, Conditions, Syndromes

US gives go-ahead to fast Ebola test

US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.

Medications

FDA OKs Cubist antibiotic for serious infections

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Medications

FDA approves AbbVie combo hepatitis C treatment

Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

page 13 from 40